3-methylhistidine has been researched along with clenbuterol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benson, DW; Chance, WT; Fischer, JE; Foley-Nelson, T; James, JH; Zhang, FS | 1 |
Asker, DS; Jairath, M; Timbrell, JA; Waterfield, CJ | 1 |
Agrawal, S; Katoch, SS; Thakur, P | 1 |
Furukawa, A; Ijiri, D; Ishimaru, Y; Kawaguchi, M; Nakashima, K; Ohtsuka, A; Shimamoto, S | 1 |
4 other study(ies) available for 3-methylhistidine and clenbuterol
Article | Year |
---|---|
Decreased myofibrillar protein breakdown following treatment with clenbuterol.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Clenbuterol; Eating; Male; Methylhistidines; Muscle Proteins; Muscles; Myofibrils; Nadolol; Rats; Rats, Inbred F344 | 1991 |
The biochemical effects of clenbuterol: with particular reference to taurine and muscle damage.
Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Creatine; Creatinine; Enzymes; Leucine; Liver Glycogen; Male; Methylhistidines; Muscle Fibers, Skeletal; Muscle Proteins; Muscles; Organ Size; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Taurine | 1995 |
Beta adrenoceptor agonists, clenbuterol, and isoproterenol retard denervation atrophy in rat gastrocnemius muscle: use of 3-methylhistidine as a marker of myofibrillar degeneration.
Topics: Acid Phosphatase; Adrenergic beta-Agonists; Alkaline Phosphatase; Amino Acids; Animals; Biomarkers; Clenbuterol; Isoproterenol; Male; Methylhistidines; Muscle Denervation; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Myofibrils; Rats; Rats, Wistar | 2003 |
Clenbuterol changes phosphorylated FOXO1 localization and decreases protein degradation in the sartorius muscle of neonatal chicks.
Topics: Animals; Animals, Newborn; Avian Proteins; Cell Nucleus; Chickens; Clenbuterol; Cytoplasm; Forkhead Box Protein O1; Gene Expression Regulation; Injections, Intraperitoneal; Methylhistidines; Muscle, Skeletal; Phosphorylation; Proteolysis; Proto-Oncogene Proteins c-akt; SKP Cullin F-Box Protein Ligases; Sympathomimetics; Ubiquitin-Protein Ligases | 2016 |